... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products:(Date:12/4/2008)... Boston, MA (PRWEB) Decembe... not be as funny as David Letterman,s nightly coun... long-term health. Here are this year,s winners, c... Letter:, , , , ,1. Blood sugar: How low should i...ugar levels is probably not the best approach to t...
(Date:12/4/2008)...s for PE Classrooms Released , , CORPUS CHR...hundreds of physical educators at the annual Texas...e (TAHPERD) conference, Source Brands, Inc., maker...ly released the first "active gaming" lesson plans... is entitled GameCoach(TM) and is available nati...
(Date:12/4/2008)...ication used for high blood pressure does not impr...ew results from a large, international study. , ...est University Baptist Medical Center in key leade...he New England Journal of Medicine , published to...hers, who continue to study other medications in s...
(Date:12/4/2008)...wswire/ -- The American Academy of,Dermatology (A...tamin D,drawing on the scientific literature to ...n adequate amount of this vitamin. The Academy re...tritional sources and dietary supplements, and,no...diation from the sun or,indoor tanning devices, a...
Breaking Medicine News(10 mins):Health News:The Top 10 Health Stories of 2008, from the Harvard Health Letter 2Health News:The Top 10 Health Stories of 2008, from the Harvard Health Letter 3Health News:The Top 10 Health Stories of 2008, from the Harvard Health Letter 4Health News:GameCoach(TM) Combines High Tech With Old School PE School Equipment 2Health News:Study finds treatment fails to improve common form of heart failure 2Health News:Study finds treatment fails to improve common form of heart failure 3Health News:American Academy of Dermatology Issues Position Statement on Vitamin D 2(Date:12/4/2008)...December 4 Biopharmaceutical compa...essfully completed treatment of the,last patient ...), a donor,lymphocyte cell based product, is unde...Disease (GvHD) and allow early immune reconstituti...tion. Nineteen end stage blood cancer,patients we...
(Date:12/4/2008)...tive TLR8 Agonist to Advance to Clinical Trials ,... Pharmaceuticals, Inc., a biopharmaceutical compan...ceptor 8 (TLR8) agonists for the treatment of canc... today that it has initiated a Phase I clinical tr...treatment of cancer. The multi-center clinical tr...
(Date:12/4/2008)...Dec. 4 NovaRx Corporation announce....D to the position of President and Chief Operatin... than 25 years experience in drug discovery and a ...maceutical discovery and development. He also has...companies developing pioneering new technologies. ...
(Date:12/4/2008)...lif.,Dec. 4 Velos, Inc., the recog...als management information systems, today announce...sity of Kansas Medical Center (KU Medical Center)... a comprehensive, system-wide roll-out that suppor...linical information needs of the institution,s cli...
Breaking Medicine Technology:Kiadis Pharma Announces Positive Clinical Results for ATIR(TM) in Mismatched Bone Marrow Transplantations 2VentiRx Pharmaceuticals Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology 2NovaRx Appoints Industry Veteran as President and COO 2NovaRx Appoints Industry Veteran as President and COO 3University of Kansas Medical Center to Deploy Velos eResearch System-Wide 2University of Kansas Medical Center to Deploy Velos eResearch System-Wide 3Statement by the American Egg Board and Egg Nutrition Center on AJCN Study on Egg Consumption 16426 1Statement by the American Egg Board and Egg Nutrition Center on AJCN Study on Egg Consumption 16426 2Statement by the American Egg Board and Egg Nutrition Center on AJCN Study on Egg Consumption 16426 3Baxters V Link Luer Activated Device With VitalShield Protective Coating Now Available For Hospitals 4501 1Baxters V Link Luer Activated Device With VitalShield Protective Coating Now Available For Hospitals 4501 2Baxters V Link Luer Activated Device With VitalShield Protective Coating Now Available For Hospitals 4501 3Baxters V Link Luer Activated Device With VitalShield Protective Coating Now Available For Hospitals 4501 4UD researchers discover novel gene toggles in worlds top food crop 2835 1UD researchers discover novel gene toggles in worlds top food crop 2835 2UD researchers discover novel gene toggles in worlds top food crop 2835 3Stenting as Good as Surgery for Stroke Prevention 16422 1Stenting as Good as Surgery for Stroke Prevention 16422 2... SAN FRANCISCO--(BUSINESS WIRE)--May 21, 2007 - Gi...results of two long-term studies,evaluating ambris...gonist (ERA) for the treatment of patients with pu...rm data are from patients,who originally participa... AMB-222, a Phase II study of patients who had,pre...
... Relationship Between Ability to Function and Trea...died, INDIANAPOLIS, May 21, 2007 /PRNewswire-First...ed anxiety disorder (GAD),treated with Cymbalta(R)...perform everyday activities at home, work and in s...rovements in global,functioning were the result of...
Other Medicine Technology:Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 2Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 3Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 4Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 5Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 6Data Suggest Cymbalta Improved Functioning in Patients with,Generalized Anxiety Disorder 2Data Suggest Cymbalta Improved Functioning in Patients with,Generalized Anxiety Disorder 3Data Suggest Cymbalta Improved Functioning in Patients with,Generalized Anxiety Disorder 4Data Suggest Cymbalta Improved Functioning in Patients with,Generalized Anxiety Disorder 5Data Suggest Cymbalta Improved Functioning in Patients with,Generalized Anxiety Disorder 6